- Home
- ABOS vs PDEX Comparison
ABOS vs PDEX Comparison
Compare ABOS & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABOS | PDEX |
|---|---|---|
| Founded | 1996 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.0M | 189.2M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ABOS | PDEX |
|---|---|---|
| Price | $2.58 | $56.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.00 | ★ $56.00 |
| AVG Volume (30 Days) | ★ 294.2K | 16.8K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 345.00 |
| EPS | N/A | ★ 3.27 |
| Revenue | N/A | ★ $66,593,000.00 |
| Revenue This Year | N/A | $7.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $18.15 |
| Revenue Growth | N/A | ★ 23.68 |
| 52 Week Low | $0.97 | $23.52 |
| 52 Week High | $3.60 | $61.62 |
Technical Indicators
Market Signals| Indicator | ABOS | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 59.94 |
| Support Level | $2.24 | $37.15 |
| Resistance Level | $3.02 | N/A |
| Average True Range (ATR) | 0.14 | 2.93 |
| MACD | 0.01 | 0.61 |
| Stochastic Oscillator | 43.64 | 72.78 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
About PDEX Pro-Dex Inc.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.